Skip to content

Frederick Streeter Barrett

3 papers in the library · 30 citations · publishing 2022-2026

Papers

Sort Most recent Most cited

Psilocybin, cognitive stability and drinking reduction in co-occurring alcohol use disorder and depression: a pilot secondary analysis of a randomized, placebo-controlled trial

medRxiv October 29, 2026 Ceyda Sayalı, Eli Weisman, Frederick Streeter Barrett preprint

Background. Change in cognitive control is a candidate transdiagnostic mechanism of psychedelic therapy. One account predicts that, once acute effects resolve, psilocybin shifts control toward flexibility while sparing inhibition and working memory. A motivational account (PRISM) predicts that psilocybin increases the willingness to exert control rather than the ability to do so. We tested both...

The psychedelic effects of cannabis: A review of the literature

Journal of Psychopharmacology November 10, 2023 David Wolinsky, Frederick Streeter Barrett, Ryan Vandrey 16 citations

Cannabis and classic psychedelics are controlled substances with emerging evidence of efficacy in the treatment of a variety of psychiatric illnesses. Cannabis has largely not been regarded as having psychedelic effects in contemporary literature, despite many examples of historical use along with classic psychedelics to attain altered states of consciousness. Research into the “psychedelic”...

Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.

Neuroscience & Biobehavioral Reviews July 1, 2022 Drummond E-Wen Mcculloch, Gitte Moos Knudsen, Frederick Streeter Barrett et al. 14 citations

Clinical research into serotonergic psychedelics is expanding rapidly, showing promising efficacy across myriad disorders. Resting-state functional magnetic resonance imaging (rs-fMRI) is a commonly used strategy to identify psychedelic-induced changes in neural pathways in clinical and healthy populations. Here we, a large group of psychedelic imaging researchers, review the 42 research...